Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more
Peijia Medical Limited (PEJMF) - Total Liabilities
Latest total liabilities as of June 2025: $614.64 Million USD
Based on the latest financial reports, Peijia Medical Limited (PEJMF) has total liabilities worth $614.64 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Peijia Medical Limited - Total Liabilities Trend (2019–2024)
This chart illustrates how Peijia Medical Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Peijia Medical Limited Competitors by Total Liabilities
The table below lists competitors of Peijia Medical Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tianjin Benefo Tejing Electric Co Ltd
SHG:600468
|
China | CN¥1.77 Billion |
|
Chengdu Spaceon Electronics Co Ltd Class A
SHE:002935
|
China | CN¥1.28 Billion |
|
UniTTEC Co Ltd
SHE:000925
|
China | CN¥5.45 Billion |
|
Tesna Inc
KQ:131970
|
Korea | ₩272.30 Billion |
|
A.G. BARR p.l.c
PINK:BAGFF
|
USA | $143.80 Million |
|
Capital City Bank Group
NASDAQ:CCBG
|
USA | $3.83 Billion |
|
Oppenheimer Holdings Inc
NYSE:OPY
|
USA | $2.90 Billion |
|
Paragon 28 Inc
NYSE:FNA
|
USA | $160.13 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Peijia Medical Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Peijia Medical Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Peijia Medical Limited (2019–2024)
The table below shows the annual total liabilities of Peijia Medical Limited from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $644.11 Million | +61.88% |
| 2023-12-31 | $397.88 Million | -41.39% |
| 2022-12-31 | $678.86 Million | +369.85% |
| 2021-12-31 | $144.48 Million | +112.49% |
| 2020-12-31 | $67.99 Million | -95.27% |
| 2019-12-31 | $1.44 Billion | -- |